Loading...
Addex Therapeutics Ltd
ADXN.SW•SIX
Healthcare
Biotechnology
CHF0.06
CHF0.00(0.00%)
Addex Therapeutics Ltd (ADXN.SW) Financial Performance & Statements
Review Addex Therapeutics Ltd’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-74.58%
↓ 74.58%
Operating Income Growth
73.20%
↑ 73.20%
Net Income Growth
166.84%
↑ 166.84%
Operating Cash Flow Growth
32.77%
↑ 32.77%
Operating Margin
-679.41%
↓ 679.41%
Gross Margin
99.65%
↑ 99.65%
Net Profit Margin
1739.88%
↑ 1739.88%
ROE
88.17%
↑ 88.17%
ROIC
-27.92%
↓ 27.92%
Addex Therapeutics Ltd (ADXN.SW) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Addex Therapeutics Ltd stock.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $1508.00 | $53837.00 | $115277.00 | $234910.00 |
Cost of Revenue | $1508.00 | $0.00 | $0.00 | -$90.00 |
Gross Profit | $0.00 | $53837.00 | $115277.00 | $235000.00 |
Gross Profit Ratio | $0.00 | $1.00 | $1.00 | $1.000 |
R&D Expenses | $65349.00 | $77847.00 | $184461.00 | $245125.00 |
SG&A Expenses | $357982.00 | $337248.00 | $507166.00 | $774939.00 |
Operating Expenses | $423331.00 | $676036.00 | $1.01M | $1.02M |
Total Costs & Expenses | -$447134.00 | $676036.00 | $1.01M | $1.02M |
Interest Income | $0.00 | $102.00 | $1507.00 | $7571.00 |
Interest Expense | $1486.00 | $586.00 | $864.00 | $611.00 |
Depreciation & Amortization | $23803.00 | $53575.00 | $112382.00 | $2938.00 |
EBITDA | -$1.16M | -$1.47M | -$1.34M | -$731633.00 |
EBITDA Ratio | -$772.24 | -$27.37 | -$11.65 | -$3.11 |
Operating Income | -$445626.00 | -$622199.00 | -$899316.00 | -$788090.00 |
Operating Income Ratio | -$295.51 | -$11.56 | -$7.80 | -$3.35 |
Other Income/Expenses (Net) | -$744205.00 | -$905373.00 | -$557445.00 | $52914.00 |
Income Before Tax | -$1.19M | -$1.53M | -$1.46M | -$735178.00 |
Income Before Tax Ratio | -$789.01 | -$28.37 | -$12.64 | -$3.13 |
Income Tax Expense | $0.00 | $0.00 | $0.00 | $3.09M |
Net Income | -$1.21M | -$1.53M | $12.88M | -$3.09M |
Net Income Ratio | -$799.56 | -$28.42 | $111.72 | -$13.14 |
EPS | -$0.01 | -$0.02 | $0.13 | -$0.03 |
Diluted EPS | -$0.01 | -$0.009 | $0.08 | -$0.03 |
Weighted Avg Shares Outstanding | $98.34M | $98.30M | $98.31M | $97.53M |
Weighted Avg Shares Outstanding (Diluted) | $98.34M | $98.30M | $167.99M | $97.53M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan